Aluminum salts are currently the only widely used adjuvant for human vaccin
es. Over the past 10-15 years, a large research effort has attempted to fin
d novel adjuvants with ability to induce a broad range of immune responses,
including cell-mediated immunity, The immunostimulating complex or ISCOM i
s one adjuvant with multiple adjuvant properties, ISCOMs are open cage-like
complexes typically with a diameter of about 40 win that are built up by c
holesterol, lipid, immunogen, and saponins from the bark of the tree Quilla
ia saponaria Molina. ISCOMs have been demonstrated to promote antibody resp
onses and induce T helper cell as well as cytotoxic T lymphocyte responses
in a variety of experimental animal models, and have now progressed to phas
e I and II human trials, This review describes recent developments in the u
nderstanding of the structure, composition, and preparation of ISCOMs and w
ill cover important aspects of the understanding of the adjuvant functions
of ISCOMs and how they act on the immune system.